Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

197.60p
   
  • Change Today:
      0.40p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 99.96m
  • Volume: 99,069
  • Market Cap: £197.52m
  • RiskGrade: 125

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-23 Interim 43.06 (52.34) (49.74)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 66.78 5.01 11.57p 61.1 n/a n/a n/a 0.0%
31-Dec-19 64.06 (20.89) (22.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 91.02 (89.52) (90.32)p n/a n/a n/a n/a 0.0%
31-Dec-24 125.10 (41.42) (42.40)p n/a n/a n/a n/a 0.0%
31-Dec-25 157.59 (23.32) (27.70)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 61.12 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

OXB Market Data

Currency UK Pounds
Share Price 197.60p
Change Today 0.40p
% Change 0.20 %
52 Week High 470.00
52 Week Low 166.80
Volume 99,069
Shares Issued 99.96m
Market Cap £197.52m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.69% above the market average44.69% above the market average44.69% above the market average44.69% above the market average44.69% above the market average
81.48% above the sector average81.48% above the sector average81.48% above the sector average81.48% above the sector average81.48% above the sector average
Price Trend
79.09% below the market average79.09% below the market average79.09% below the market average79.09% below the market average79.09% below the market average
43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average
Income Not Available
Growth
4.68% above the market average4.68% above the market average4.68% above the market average4.68% above the market average4.68% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 7
Sell 0
Strong Sell 0
Total 10
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
15:26 152 @ 197.60p
15:26 208 @ 197.40p
15:26 577 @ 197.40p
15:26 174 @ 197.40p
15:16 446 @ 197.40p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page